BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8900604)

  • 1. [Effectiveness and tolerance of Navoban (5HT3-receptor antagonist tropisetron) in prevention of cytostatic drug-induced nausea and vomiting in patients with breast carcinomas and gynecological malignancies].
    Regidor PA; Nelken B; Regidor M; Bier U; Oberhoff C; Schindler AE
    Zentralbl Gynakol; 1996; 118(3):148-53. PubMed ID: 8900604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The antiemetic action of tropisetron (Navoban) in the cytostatic treatment of neoplastic diseases].
    Buiuc AI; Găleşanu MR
    Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):160-4. PubMed ID: 9455457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
    Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
    Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Granisetron, a new and potent antiemetic for treatment of cytostatic drug-induced vomiting in gynecological malignancies].
    Regidor PA; Schindler AE
    Geburtshilfe Frauenheilkd; 1994 Jan; 54(1):51-4. PubMed ID: 8150251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM
    Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).
    Morrow GR; Hickok JT; Rosenthal SN
    Cancer; 1995 Aug; 76(3):343-57. PubMed ID: 8625113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tropisetron in the prevention of acute and delayed nausea and vomiting over six courses of emetogenic chemotherapy.
    Bleiberg H; Hulstaert F; Buyse M; De Keyser P
    Anticancer Drugs; 1998 Oct; 9(9):773-7. PubMed ID: 9840722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-emetic efficacy of tropisetron plus dexamethasone in patients treated with high-dose chemotherapy and stem cell transplantation.
    Barbounis V; Koumakis G; Hatzichristou H; Vassilomanolakis M; Tsoussis S; Efremidis A
    Support Care Cancer; 1999 Mar; 7(2):79-83. PubMed ID: 10089087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tropisetron hydrochloride in preventing and treating chemotherapy-induced nausea and vomiting: a phase II, randomized, multicenter, double-blinded, comparative clinical trial].
    Zhang WD; Wang XW; Chen ZD; Qin FZ; Shu YQ; Pan LX; Zhang MH
    Ai Zheng; 2007 Aug; 26(8):870-3. PubMed ID: 17697550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of nausea and vomiting by Navoban (tropisetron) in 131 children receiving cytotoxic chemotherapy.
    Benoit Y; Hulstaert F; Vermylen C; Sariban E; Hoyoux C; Uyttebroeck A; Otten J; Laureys G; De Kerpel I; Nortier D
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():9-14. PubMed ID: 7749170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting--the Nordic experience.
    Sorbe B; Andersson H; Schmidt M; Söderberg M; Högberg T; Wernstedt L; Janson ET; Ehrnström B; Kjaer M; Havsteen H
    Support Care Cancer; 1994 Nov; 2(6):393-9. PubMed ID: 7858934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Andersson H; Hansen O; Sørensen BT; Räisänen I
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():31-6. PubMed ID: 7749168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tropisetron (Navoban) in the control of nausea and vomiting induced by combined cancer chemotherapy in children.
    Ozkan A; Yildiz I; Yüksel L; Apak H; Celkan T
    Jpn J Clin Oncol; 1999 Feb; 29(2):92-5. PubMed ID: 10089950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preventive efficacies of china-made tropisetron hydrochloride and Navoban on chemotherapy-induced nausea and vomiting: a randomized controlled clinical trial].
    Xie M; Wu HY; Guo Y; Liu JL; Guan ZZ; Liu YL; Wang PH; Chen Q; Huang P; Yang JW
    Ai Zheng; 2005 Aug; 24(8):998-1001. PubMed ID: 16086881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe B; Hallén C; Frankendal B
    Cancer Chemother Pharmacol; 1994; 33(4):298-302. PubMed ID: 8281622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban Group.
    Van Belle SJ; Cocquyt VF; Bleiberg H; Canon JL; Buyse M; Hulstaert F; De Witte M; De Keyser P; Westelinck K
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():22-30. PubMed ID: 7749166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
    Aksoylar S; Akman SA; Ozgenç F; Kansoy S
    Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.